These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 19746575)

  • 21. Effects of pharmacological treatments on micro- and macrovascular complications of type 2 diabetes: what is the level of evidence?
    Boussageon R; Gueyffier F; Cornu C
    Diabetes Metab; 2014 Jun; 40(3):169-75. PubMed ID: 24503191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [New studies, new strategies, new guidelines: so that diabetic patients will live longer].
    Aumiller J
    MMW Fortschr Med; 2005 Oct; 147(41):4-6. PubMed ID: 16270500
    [No Abstract]   [Full Text] [Related]  

  • 23. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.
    Lancet; 1998 Sep; 352(9131):837-53. PubMed ID: 9742976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin in type 2 diabetes: a useful alternative despite limited assessment based on surrogate endpoints.
    Prescrire Int; 2005 Oct; 14(79):187-93. PubMed ID: 16285076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Associations of HbA1c and educational level with risk of cardiovascular events in 32,871 drug-treated patients with Type 2 diabetes: a cohort study in primary care.
    Östgren CJ; Sundström J; Svennblad B; Lohm L; Nilsson PM; Johansson G
    Diabet Med; 2013 May; 30(5):e170-7. PubMed ID: 23350893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin glargine added to therapy with oral antidiabetic agents improves glycemic control and reduces long-term complications in patients with type 2 diabetes - a simulation with the Diabetes Mellitus Model (DMM).
    Janka HU; Hessel F; Walzer S; Mã Ller E
    Int J Clin Pharmacol Ther; 2007 Dec; 45(12):623-30. PubMed ID: 18184530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term effects of metformin on metabolism and microvascular and macrovascular disease in patients with type 2 diabetes mellitus.
    Kooy A; de Jager J; Lehert P; Bets D; Wulffelé MG; Donker AJ; Stehouwer CD
    Arch Intern Med; 2009 Mar; 169(6):616-25. PubMed ID: 19307526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucose-lowering treatment and clinical results in 163 121 patients with type 2 diabetes: an observational study from the Swedish national diabetes register.
    Ekström N; Miftaraj M; Svensson AM; Andersson Sundell K; Cederholm J; Zethelius B; Gudbjörnsdottir S; Eliasson B
    Diabetes Obes Metab; 2012 Aug; 14(8):717-26. PubMed ID: 22364580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. United Kingdom Prospective Diabetes Study 24: a 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy. United Kingdom Prospective Diabetes Study Group.
    Ann Intern Med; 1998 Feb; 128(3):165-75. PubMed ID: 9454524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [New clinical data with metformin therapy in patients with diabetes mellitus].
    Jermendy G
    Orv Hetil; 2010 Dec; 151(49):2025-30. PubMed ID: 21106483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diabetic complications: good metabolic control protects].
    MMW Fortschr Med; 2011 Apr; 153(15):44-5. PubMed ID: 21667560
    [No Abstract]   [Full Text] [Related]  

  • 32. [The effect of metformin on late diabetic complications and cardiovascular events in obese patients with type 2 diabetes].
    Christiansen AL; Madsbad S
    Ugeskr Laeger; 2002 Apr; 164(15):2022-4. PubMed ID: 11984999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intensive glucose control and cardiovascular outcomes in type 2 diabetes.
    Macisaac RJ; Jerums G
    Heart Lung Circ; 2011 Oct; 20(10):647-54. PubMed ID: 20807681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of type 2 diabetes: the sooner, the better.
    Yamada T; Komatsu M; Sato A; Komiya I; Yamauchi K; Aizawa T; Hashizume K
    J Intern Med; 2001 Sep; 250(3):255-7. PubMed ID: 11555131
    [No Abstract]   [Full Text] [Related]  

  • 35. Overview of insulin replacement therapy.
    Wright EE
    J Fam Pract; 2009 Aug; 58(8 Suppl):S3-9. PubMed ID: 19679029
    [No Abstract]   [Full Text] [Related]  

  • 36. Options for intensifying diabetes treatment.
    Reid TS
    J Fam Pract; 2011 Sep; 60(9 Suppl):S7-10. PubMed ID: 21912777
    [No Abstract]   [Full Text] [Related]  

  • 37. [Intensive blood sugar treatment in type 2 diabetics: no evidence for increased mortality in the ADVANCE study compared with ACCORD study].
    Füchtenbusch M; Hummel M
    MMW Fortschr Med; 2008 Apr; 150(17):42-4. PubMed ID: 18510157
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment of type 2 diabetes: inadequate assessment of oral antidiabetic combinations.
    Prescrire Int; 2003 Feb; 12(63):28-30. PubMed ID: 12602406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An economic evaluation of colesevelam when added to metformin-, insulin- or sulfonylurea-based therapies in patients with uncontrolled type 2 diabetes mellitus.
    Simons WR; Hagan MA
    Pharmacoeconomics; 2010; 28(9):765-80. PubMed ID: 20799756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diabetes and cardiovascular disease: the role of glycemic control.
    Cheng AY; Leiter LA
    Curr Diab Rep; 2009 Feb; 9(1):65-72. PubMed ID: 19192427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.